# Phase 2 Acute Kidney Injury trials recruiting: 26 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 26 trials in phase 2 for Acute Kidney Injury that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 Acute Kidney Injury trials: 26 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/acute-kidney-injury

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 26
- Recruiting or not yet: 26
- Read on: November 19, 2026

## Trials

The 25 newest of 26, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 19, 2026 | NCT07880951 | Amino Acid Therapy Evaluating the Incidence of New-Onset AKI | Children's Hospital Medical Center, Cincinnati | Phase 2 | Not yet recruiting | Acute Kidney Injury | 270 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07880951) |
| July 31, 2026 | NCT07738328 | Terbinafine for CSA-AKI Prevention | Guangdong Provincial People's Hospital | Phase 2 | Not yet recruiting | Acute Kidney Injury, Cardiac Surgical Procedures | 208 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07738328) |
| June 29, 2026 | NCT07672860 | Perioperative Ursodeoxycholic Acid for Renal Protection in Adults Undergoing Partial Nephrectomy for Renal Tumors | Jinling Hospital, China | Phase 2 | Recruiting | Kidney Cancer | 162 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07672860) |
| June 22, 2026 | NCT07661940 | Efficacy and Safety of SP16 in Preventing Acute Kidney Injury in At-risk Subjects With Chronic Kidney Disease Undergoing Elective Cardiac... | University of Erlangen-Nürnberg Medical School | Phase 2 | Recruiting | AKI - Acute Kidney Injury | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07661940) |
| June 4, 2026 | NCT07625553 | Study of the Relaxin Agonist R2R01 in Patients at High Risk for Cardiac Surgery Associated- Acute Kidney Injury | River 2 Renal Corp. | Phase 2 | Recruiting | Acute Kidney Injury | 430 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07625553) |
| June 1, 2026 | NCT07617948 | Intravesical Aminophylline for Urgent Ureteral Stenting in Acute Calculous Anuria | Beni-Suef University | Phase 2 | Recruiting | Acute Calculous Anuria, Ureteral Calculi, Obstructive Uropathy, Acute Kidney Injury | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07617948) |
| February 27, 2026 | NCT07438262 | The AminoECMO Pilot Trial | Australian and New Zealand Intensive Care Research Centre | Phase 2 | Not yet recruiting | Acute Kidney Injury | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07438262) |
| December 10, 2025 | NCT07273838 | Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome | Yale University | Phase 2 | Recruiting | Heart Failure, Acute Kidney Injury | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07273838) |
| December 3, 2025 | NCT07262060 | Improving Preterm Kidney Outcomes With Caffeine | University of Wisconsin, Madison | Phase 2 | Recruiting | Kidney Injury, Pre-Term | 114 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07262060) |
| November 14, 2025 | NCT07229040 | A Double-blind Non Inferiority Clinical Trial to Compare the Nephroprotection of Cilastatn Versus Thiosulfate in Patients Undergoing... | Hospital General Universitario Gregorio Marañon | Phase 2 | Recruiting | Debulking Surgery for Ovarian Cancer, Acute Kidney Injury | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07229040) |
| November 5, 2025 | NCT07224997 | Trimethoprim-Sulfamethoxazole (TMP/SMX) Prophylaxis After Acute Kidney Injury to Prevent Post-discharge Infections | Hospital Civil de Guadalajara | Phase 2 | Not yet recruiting | Acute Kidney Injuries, Acute Kidney Disease, Acute Kidney Injury (AKI) | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07224997) |
| October 10, 2025 | NCT07215702 | A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury. | AstraZeneca | Phase 2 | Recruiting | Sepsis, Acute Kidney Injury | 124 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07215702) |
| October 8, 2025 | NCT07212595 | Biomarker and Renal Angina Validation to Assess Heart-Kidney Outcomes After Amino Acid Therapy | Sponsor not shown (see the record) | Phase 2 | Recruiting | Acute Kidney Injury, Mechanical Ventilation | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07212595) |
| June 11, 2025 | NCT07016074 | Inorganic Nitrate (NaNO3) Prevention of Contrast-Associated Acute Kidney Injury | University of Michigan | Phase 2 | Recruiting | Kidney Injury, Acute | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07016074) |
| June 10, 2025 | NCT07013591 | Nicotinamide Mononucleotide in Patients Undergoing Cardiac Surgery | Brigham and Women's Hospital | Phase 2 | Recruiting | Cardiac Surgery | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07013591) |
| June 3, 2025 | NCT07001098 | Amino Acids for Cardiac Surgery Associated AKI | Stanford University | Phase 2 | Not yet recruiting | Acute Kidney Injury | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07001098) |
| May 2, 2025 | NCT06954740 | Clinical Study to Evaluate the Efficacy and Safety of Mesenchymal Stromal Cells (Amimestrocel ) in Patients With Acute Kidney Injury | Chinese PLA General Hospital | Phase 2 | Recruiting | Acute Kidney Injury | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06954740) |
| April 22, 2025 | NCT06937307 | Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury | Sponsor not shown (see the record) | Phase 2 | Recruiting | Acute Kidney Injury, Cirrhosis, Decompensated Cirrhosis of Liver | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06937307) |
| March 20, 2025 | NCT06886464 | Prevention of Nephrotoxin-Induced Acute Kidney Injury Using Cilastatin | Sponsor not shown (see the record) | Phase 2 | Recruiting | Acute Kidney Injury | 698 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06886464) |
| November 26, 2024 | NCT06706258 | Post-Cardiac Surgery Acute Kidney Injury Prevention by Administration of Proton Pump Inhibitor (P2 Trial) | The University of Texas Health Science Center, Houston | Phase 2 | Recruiting | Acute Kidney Injury | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06706258) |
| November 21, 2024 | NCT06699849 | Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis | CSL Behring | Phase 2 | Recruiting | Sickle Cell Disease Vaso-occlusive Crisis | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06699849) |
| July 30, 2024 | NCT06528405 | The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease | National Taiwan University Hospital | Phase 2 | Recruiting | Acute Kidney Injury | 264 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06528405) |
| June 18, 2023 | NCT05909150 | Hypertonic Saline Solution to Prevent Acute Kidney Injury After Heart Transplantation | Sponsor not shown (see the record) | Phase 2 | Recruiting | Heart Transplantation, Acute Kidney Injury | 74 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05909150) |
| May 30, 2023 | NCT05879432 | LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery | Arch Biopartners Inc. | Phase 2 | Recruiting | Acute Kidney Injury, Cardiac Surgery | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05879432) |
| May 25, 2023 | NCT05875948 | Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome | River 2 Renal Corp. | Phase 2 | Recruiting | Hepatorenal Syndrome, Acute Kidney Injury | 95 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05875948) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| River 2 Renal Corp. | 2 |
| Beni-Suef University | 1 |
| Stanford University | 1 |
| Australian and New Zealand Intensive Care Research Centre | 1 |
| University of Michigan | 1 |
| Brigham and Women's Hospital | 1 |
| National Taiwan University Hospital | 1 |
| University of Wisconsin, Madison | 1 |
| Jinling Hospital, China | 1 |
| [CSL Behring](https://specstream.ai/data/clinical-trials/company/csl-behring) | 1 |
| Chinese PLA General Hospital | 1 |
| Hospital General Universitario Gregorio Marañon | 1 |
| Arch Biopartners Inc. | 1 |
| The University of Texas Health Science Center, Houston | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 1 |
| University of Erlangen-Nürnberg Medical School | 1 |
| Guangdong Provincial People's Hospital | 1 |
| Yale University | 1 |
| University Hospital, Montpellier | 1 |
| Hospital Civil de Guadalajara | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 11 |
| China | 3 |
| Turkey (Türkiye) | 3 |
| Canada | 3 |
| United Kingdom | 2 |
| Spain | 2 |
| France | 2 |
| Germany | 2 |
| Italy | 2 |
| Egypt | 1 |
| Australia | 1 |
| Taiwan | 1 |
| Brazil | 1 |
| Argentina | 1 |
| Belgium | 1 |
| Czechia | 1 |
| Denmark | 1 |
| Greece | 1 |
| Hungary | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [B2B scientific equipment companies in the United States](https://specstream.ai/data/businesses/b2b-scientific-equipment-companies/united-states)
- [Indian restaurants in the United States](https://specstream.ai/data/businesses/indian-restaurants/united-states)
- [Telecommunications services in the United States](https://specstream.ai/data/businesses/telecommunications-services/united-states)
- [Doctors' offices in the United States](https://specstream.ai/data/businesses/doctors-offices/united-states)
- [Payroll companies in the United States](https://specstream.ai/data/businesses/payroll-companies/united-states)
- [B2B medical support companies in the United States](https://specstream.ai/data/businesses/b2b-medical-support-companies/united-states)
